Medical Research
(H41)
IRS Verified
DX Registered
990 on File
OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC
Financial strength (30%)
63/100
Reliability (20%)
55/100
Effectiveness (25%)
58/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The Ocular Immunology and Uveitis Foundation is a 501c(3) national non-profit organization dedicated to: Finding cures for ocular inflammatory diseases Erasing the worldwide deficit of properly trained ocular immunologists, and Providing education and emotional support for those patients afflicted with ocular inflammatory disease. Inflammatory eye diseases are responsible for an estimated 10–15% of blindness in developed countries, often affecting children and working-age adults and creating a s
Financial Overview — FY 2024
$1.6M
Total Revenue
$707K
Total Expenses
$3.0M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
63.4%
Fundraising Efficiency
108.2%
Operating Reserve
51.00x
Liability-to-Asset
0.1%
Revenue Diversification
83.5%
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
63.4% | 84.5% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.3% | 11.4% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
26.3% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
108.2% | 10.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
51.0 mo | 13.4 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.1% | 0.4% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
83.5% | 93.3% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-4.4% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
0.3% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
54.9% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $1.6M | $707K | $3.0M | 63.4% | 0 |
| 2023 | $1.6M | $705K | $2.1M | 66.6% | 0 |
| 2022 | $734K | $734K | $1.0M | 80.9% | 0 |
| 2021 | $676K | $651K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.